查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球一次性反應器市場：按產品、按類型、按分子類型、按細胞類型、按應用、按最終用戶、按地區 - 預測到 2029 年
市場調查報告書
商品編碼
1526812

全球一次性反應器市場：按產品、按類型、按分子類型、按細胞類型、按應用、按最終用戶、按地區 - 預測到 2029 年

Single-Use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 443 Pages | 訂單完成後即時交付

價格

全球一次性反應器（SUB）市場規模預計將從 2024 年的 44 億美元增至 2029 年的 91 億美元，2024-2029 年預測期間複合年成長率為 15.4%，值得關注。

SUB相對於傳統反應器的優勢是市場擴張的驅動力。 SUB 由高級塑膠材質製成，適合一次性使用，無需在批次之間進行滅菌或清洗。這顯著降低了交叉污染的風險並提高了工作效率。 SUB 作為一次性生物製程領域的基礎技術的興起，徹底改變了生物製藥的開發和製造。與傳統不銹鋼反應器相比，它們具有優越性，使其成為生物製藥公司、CMO 和研究機構的首選。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（十億美元）
部分 按產品、按類型、按分子類型、按細胞類型、按應用、按最終用戶、按區域
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

2023年，以最終用戶計算，製藥和生物技術公司細分市場在全球一次性反應器市場中佔據最大佔有率。這一市場成長歸因於製藥、生物製藥和生物技術公司不斷增加的研發舉措以及生技藥品和生物相似藥產量的增加。此外，製藥和生物技術公司在北美和歐洲等成熟市場和新興市場廣泛使用SUB，以及這些地區核准的生技藥品和生物學名藥數量不斷增加，這是支持這一終端成長的主要因素。

美國是全球最大的生物製藥市場，也是生物製藥研究和投資的領導者。美國製藥公司正積極參與生技藥品和生物相似藥的開發，增加一次性反應器的使用，其周轉時間短、安裝成本低且能源效率高。這些因素支撐著美國一次性反應器市場的成長。此外，許多生技藥品的到期也促進了美國生物製藥產業的成長。美國的到期專利數量最多。美國製藥公司正在採取多種策略，包括開發生物相似藥、專有藥物的新劑型、已知藥物的新給藥途徑以及延長生物製藥商業性生命週期的組合。由於污染風險低且實施成本低，一次性反應器預計將在生物製藥公司的研發中得到更多採用。這些因素正在支持該國一次性反應器市場的成長。

本報告研究了全球一次性反應器市場，包括按產品、類型、分子類型、細胞類型、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 生態系分析
  • 技術分析
  • 專利分析
  • 2024-2025年重大會議和活動
  • 監管狀況
  • 投資金籌措場景
  • 波特五力分析
  • 主要相關人員和採購標準
  • 貿易分析
  • 生成式人工智慧對一次性反應器市場的影響

第6章一次性反應器市場（按產品）

  • 介紹
  • 一次性反應器系統
  • 一次性介質袋
  • 一次組裝
  • 其他

第7章一次性反應器市場（按類型）

  • 介紹
  • 攪拌槽一次性反應器
  • 波誘導一次性反應器
  • 泡殼管柱一次性反應器
  • 其他

第8章一次性反應器市場（按分子類型）

  • 介紹
  • 單株抗體
  • 疫苗
  • 治療性蛋白質和胜肽
  • 幹細胞
  • 細胞/基因治療

第9章一次性反應器市場（按細胞類型）

  • 介紹
  • 哺乳動物細胞
  • 細菌細胞
  • 酵母菌細胞
  • 其他

第10章 一次性反應器市場（依應用）

  • 介紹
  • 生物生產
  • 製程開發
  • 研究與開發

第11章一次性反應器市場（按最終用戶）

  • 介紹
  • 製藥和生物技術公司
  • 合約研究官（CRO）和首席行銷長（CMO）
  • 學術研究所

第12章一次性反應器市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第13章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 企業價值評估及財務指標
  • 品牌/產品比較
  • 競爭場景

第14章 公司簡介

  • 主要參與企業
    • SARTORIUS AG
    • DANAHER CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • AVANTOR, INC.
    • REPLIGEN CORPORATION
    • GETINGE AB
    • EPPENDORF SE
    • PARKER HANNIFIN CORPORATION
    • ENTEGRIS
    • SAINT-GOBAIN
    • CORNING INCORPORATED
    • LONZA
    • TECNIC BIOPROCESS EQUIPMENT MANUFACTURING
    • FUJIMORI KOGYO CO., LTD.
  • 其他公司
    • KUHNER AG
    • OMNIBRX BIOTECHNOLOGIES
    • NEW HORIZON BIOTECHNOLOGY, INC.
    • PBS BIOTECH, INC.
    • BBI-BIOTECH GMBH
    • ABEC, INC.
    • ESCO LIFESCIENCES GROUP LTD.
    • DISTEK, INC.
    • SATAKE MULTIMIX CORPORATION
    • CELL CULTURE COMPANY, LLC
    • MICRO DIGITAL CO., LTD.
    • CELLTAINER BIOTECH BV
    • MEISSNER FILTRATION PRODUCTS, INC.
    • SOLIDA BIOTECH GMBH
    • G&G TECHNOLOGIES, INC.
    • PHARMNXT BIOTECH
    • TOFFLON LIFE SCIENCE CO., LTD.
    • SHANGHAI LEPURE BIOTECH CO., LTD.

第15章附錄

Product Code: BT 2863

The global single-use bioreactors market is projected to reach USD 9.1 billion by 2029 from USD 4.4 billion in 2024, at a CAGR of 15.4% during the forecast period of 2024 to 2029. The advantages of SUBs above conventional bioreactors drive the market expansion. Made of premium plastic materials, SUBs are intended for single-use use hence sterilizing and cleaning between batches is not necessary. This lowers cross-contamination risk greatly and increases operational effectiveness. The rise of SUBs as a fundamental technology inside the single-use bioprocessing sector has transformed the development and manufacturing of biopharmaceutical products. Their benefits over traditional stainless-steel bioreactors make them the preferred option for biopharmaceutical companies, CMOs, and research facilities.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsProduct, Type, Molecule Type, Cell Type, Application, And End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The pharmaceutical & biotechnology companies segment accounted for the largest share by end user in 2023."

In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share by end user in the global single-use bioreactors market. The growth in this market can be attributed to rising R&D initiatives by pharmaceutical, biopharmaceutical, and biotechnology companies and the increased production of biologics and biosimilars. Moreover, the widespread use of SUBs among pharmaceutical and biotechnology companies across established and developed markets, such as North America and Europe, and the rising approvals of biologics and biosimilars in these regions are the major factors supporting the growth of this end-user segment.

"The US has continued to dominate the single-use bioreactors market during the forecast period of 2024-2029."

The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Pharmaceutical companies in the US are actively participating in developing biologics and biosimilars and increasingly utilizing single-use bioreactors, which offers less turnaround time, has low installation costs, and is energy-efficient. These factors support the growth of the US single-use bioreactors market. Furthermore, the expiry of many biologics contributes to the growth of the biopharmaceutical industry in the US. The US accounts for the highest number of patents due for expiration. Several strategies are being undertaken by pharmaceutical companies in the US, such as the development of biosimilars, new formulations for patented drugs, new routes of administration for known drugs, and combinations for extending drug commercial lifecycles, which will result in an increase in biopharmaceutical R&D and new generations of biologic medicines. As single-use bioreactors are associated with a low risk of contamination and low implementation costs, their adoption in biopharmaceutical companies for R&D is expected to increase. These factors are supporting the growth of the single-use bioreactors market in the country.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Sartorius AG (Germany)

Danaher Corporation (US)

Thermo Fisher Scientific Inc. (US)

Merck KGaA (Germany)

Avantor, Inc. (US)

Repligen Corporation (US)

Getinge AB (Sweden)

Eppendorf SE (Germany)

Parker Hannifin Corporation (US)

Entegris (US)

Saint-Gobain (France)

Corning Incorporated (US)

Lonza (Switzerland)

TECNIC Bioprocess Equipment Manufacturing (Spain)

FUJIMORI KOGYO CO., LTD. (Japan)

Kuhner AG (Switzerland)

OmniBRx Biotechnologies (India)

New Horizon Biotechnology, Inc. (US)

PBS Biotech, Inc. (US)

bbi-biotech GmbH (Germany)

ABEC, Inc. (US)

Esco Lifesciences Group Ltd. (US)

Distek, Inc. (US)

SATAKE MultiMix Corporation (Japan)

Cell Culture Company, LLC (US)

Micro Digital Co., Ltd. (South Korea)

Celltainer Biotech B.V. (Netherlands)

Meissner Filtration Products, Inc. (US)

Solida Biotech GmbH (Germany)

G&G Technologies, Inc. (US)

PharmNXT Biotech (India)

Tofflon Life Science Co., Ltd. (China)

Research Coverage:

This research report categorizes the single-use bioreactors market by product (single-use bioreactor systems, single-use media bags, single-use assemblies, and other products), by type (stirred-tank single-use bioreactors, wave-induced single-use bioreactors, bubble-column single-use bioreactors, and other single-use bioreactors), by molecule type (monoclonal antibodies (mAbs), vaccines, therapeutic proteins & peptides, stem cells, and cell & gene therapy), by cell type (mammalian cells, bacterial cells, yeast cells, and other cells), by application (bioproduction, process development, and research & development (R&D)), by end user (pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations (CROs & CMOs), and academic & research institutes) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use bioreactors market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the single-use bioreactors market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioreactors market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (growing adoption among CDMOs, CMOs, and SMEs, advantages over conventional bioreactors, reduced capital investment, reduced water and energy consumption, growing biologics & biosimilars markets), restraints (issues related to extractables & leachables, regulatory hurdles and compliance issues, and, the impact of PFAS restrictions on product development), opportunities (untapped market potential in emerging economies and hybrid facilities), and Challenges (lack of standardization, waste disposal, and potential breakage of SU bags) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the single-use bioreactors market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use bioreactors market
  • Competitive Assessment: Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Entegris (US), Getinge AB (Sweden), Parker Hannifin Corporation (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 MARKET ESTIMATION
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS
  • 2.8 GENERATIVE AI IMPACT ON SINGLE-USE BIOREACTORS MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SINGLE-USE BIOREACTORS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION AND COUNTRY (2023)
  • 4.3 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024 VS. 2029
  • 4.4 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing adoption among CDMOs, CMOs, and SMEs
      • 5.2.1.2 Advantages over conventional bioreactors
      • 5.2.1.3 Reduced capital investment
      • 5.2.1.4 Reduced water and energy consumption
      • 5.2.1.5 Growing biologics & biosimilars markets
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Issues related to extractables & leachables
      • 5.2.2.2 Regulatory hurdles and compliance issues
      • 5.2.2.3 Impact of PFAS restrictions on product development
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Untapped market potential in emerging economies
      • 5.2.3.2 Hybrid facilities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of standardization
      • 5.2.4.2 Waste disposal
      • 5.2.4.3 Potential breakage of SU bags
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023
    • 5.4.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION, 2023
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 SINGLE-USE BIOREACTORS MARKET: RAW MATERIAL SUPPLIERS
    • 5.7.2 SINGLE-USE BIOREACTORS MARKET: MANUFACTURERS
    • 5.7.3 SINGLE-USE BIOREACTORS MARKET: END USERS
    • 5.7.4 SINGLE-USE BIOREACTORS MARKET: REGULATORY BODIES
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Fermentation
      • 5.8.1.2 Continuous bioprocessing
      • 5.8.1.3 3D cell culture
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.3 ADJACENT TECHNOLOGIES
  • 5.9 PATENT ANALYSIS
  • 5.10 KEY CONFERENCES AND EVENTS IN 2024-2025
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 REGULATORY SCENARIO
      • 5.11.1.1 North America
        • 5.11.1.1.1 US
        • 5.11.1.1.2 Canada
      • 5.11.1.2 Europe
        • 5.11.1.2.1 Germany
        • 5.11.1.2.2 UK
      • 5.11.1.3 Asia Pacific
        • 5.11.1.3.1 Japan
        • 5.11.1.3.2 China
      • 5.11.1.4 Latin America
        • 5.11.1.4.1 Brazil
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 INVESTMENT & FUNDING SCENARIO
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA FOR END USERS
  • 5.15 TRADE ANALYSIS
  • 5.16 IMPACT OF GENERATIVE AI ON SINGLE-USE BIOREACTORS MARKET

6 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 SINGLE-USE BIOREACTOR SYSTEMS
    • 6.2.1 <=10 L BIOREACTORS
      • 6.2.1.1 Flexibility in early-stage R&D to boost market
    • 6.2.2 11-100 L BIOREACTORS
      • 6.2.2.1 Scalability for process development to drive demand
    • 6.2.3 101-500 L BIOREACTORS
      • 6.2.3.1 Efficiency in pilot-scale production to propel demand
    • 6.2.4 501-1500 L BIOREACTORS
      • 6.2.4.1 Growing use in large-scale commercial production to drive market
    • 6.2.5 >1500 L BIOREACTORS
      • 6.2.5.1 Rising adoption of single-use technologies in high-demand applications to support market growth
  • 6.3 SINGLE-USE MEDIA BAGS
    • 6.3.1 2D SINGLE-USE MEDIA BAGS
      • 6.3.1.1 Wide use of 2D bags in cell culture applications to drive market growth
    • 6.3.2 3D SINGLE-USE MEDIA BAGS
      • 6.3.2.1 Usage in large-volume applications to drive market growth
    • 6.3.3 OTHER SINGLE-USE MEDIA BAGS
  • 6.4 SINGLE-USE ASSEMBLIES
    • 6.4.1 OPERATIONAL EFFICIENCY AND FLEXIBILITY TO PROPEL DEMAND FOR SINGLE-USE ASSEMBLIES
  • 6.5 OTHER PRODUCTS

7 SINGLE-USE BIOREACTORS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 STIRRED-TANK SINGLE-USE BIOREACTORS
    • 7.2.1 GROWING PREFERENCE FOR AEROBIC MICROBIAL CELL CULTURES TO SUPPORT MARKET GROWTH
  • 7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS
    • 7.3.1 GROWING ADOPTION FOR SHEAR STRESS-SENSITIVE CELL LINES TO FUEL GROWTH
  • 7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS
    • 7.4.1 EFFICIENT MASS AND HEAT TRANSFER CAPABILITY TO DRIVE GROWTH
  • 7.5 OTHER SINGLE-USE BIOREACTORS

8 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE

  • 8.1 INTRODUCTION
  • 8.2 MONOCLONAL ANTIBODIES
    • 8.2.1 GROWING FOCUS ON THERAPEUTIC APPLICATIONS TO DRIVE DEMAND FOR SINGLE-USE BIOREACTORS
  • 8.3 VACCINES
    • 8.3.1 USE OF SINGLE-USE SYSTEMS FOR VACCINE PRODUCTION TO BOOST MARKET GROWTH
  • 8.4 THERAPEUTIC PROTEINS & PEPTIDES
    • 8.4.1 ABILITY OF SINGLE-USE TECHNOLOGIES TO HELP MINIMIZE CROSS-CONTAMINATION RISK TO BOOST ADOPTION
  • 8.5 STEM CELLS
    • 8.5.1 GROWING RESEARCH AND COMMERCIALIZATION OF STEM CELL THERAPIES TO DRIVE MARKET
  • 8.6 CELL & GENE THERAPY
    • 8.6.1 INCREASING RESEARCH INITIATIVES FOR GENE AND CELL THERAPIES TO DRIVE MARKET

9 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE

  • 9.1 INTRODUCTION
  • 9.2 MAMMALIAN CELLS
    • 9.2.1 GROWING USE OF MAMMALIAN CELLS IN PRODUCTION OF MONOCLONAL ANTIBODIES TO DRIVE MARKET
  • 9.3 BACTERIAL CELLS
    • 9.3.1 GROWING ADOPTION IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION TO DRIVE MARKET
  • 9.4 YEAST CELLS
    • 9.4.1 HIGH GROWTH RATE AND MINIMAL MEDIA CONDITIONS TO DRIVE ADOPTION IN RECOMBINANT PROTEIN PRODUCTION
  • 9.5 OTHER CELLS

10 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 BIOPRODUCTION
    • 10.2.1 INCREASING BIOPHARMACEUTICAL PRODUCTION TO DRIVE DEMAND FOR COST-EFFECTIVE SINGLE-USE BIOREACTORS
  • 10.3 PROCESS DEVELOPMENT
    • 10.3.1 ACCELERATED TIME-TO-MARKET TO PROPEL ADOPTION
  • 10.4 RESEARCH & DEVELOPMENT
    • 10.4.1 RISING ADOPTION OF SINGLE-USE BIOREACTORS FOR COST-EFFECTIVENESS TO DRIVE MARKET

11 SINGLE-USE BIOREACTORS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 GROWING BIOLOGICS AND BIOSIMILARS MARKET TO INCREASE DEMAND FOR SINGLE-USE BIOREACTORS
  • 11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
    • 11.3.1 INCREASING OUTSOURCING OF R&D AND MANUFACTURING TO SUPPORT MARKET GROWTH
  • 11.4 ACADEMIC & RESEARCH INSTITUTES
    • 11.4.1 COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET

12 SINGLE-USE BIOREACTORS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 US to dominate North American market during study period
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing government support for biologics manufacturing and rising research funding to propel market growth
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 High government R&D investment and technological advancements to aid market growth
    • 12.3.2 UK
      • 12.3.2.1 Increased government funding for pharmaceutical & biotechnology research to boost market growth
    • 12.3.3 FRANCE
      • 12.3.3.1 Favorable government initiatives and increased investments by foreign pharmaceutical companies to augment market growth
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing government grants for biopharmaceutical and life science research to support market
    • 12.3.5 SPAIN
      • 12.3.5.1 Rising focus on personalized medicine to fuel market growth
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Low manufacturing costs and high investments in biotechnology sector to spur market growth
    • 12.4.2 SOUTH KOREA
      • 12.4.2.1 Increased focus on quality manufacturing practices to aid market growth
    • 12.4.3 JAPAN
      • 12.4.3.1 Increasing collaborations among biotechnology companies to drive market
    • 12.4.4 INDIA
      • 12.4.4.1 High foreign direct investments and favorable government policies to propel market growth
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Increased demand for innovative research solutions and developed pharmaceutical industry to support market growth
    • 12.4.6 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Increasing pharmaceutical R&D to fuel market growth
    • 12.5.2 MEXICO
      • 12.5.2.1 Increased foreign direct investment from US and reduced pharmaceutical manufacturing costs to boost market growth
    • 12.5.3 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 GCC COUNTRIES
      • 12.6.1.1 Saudi Arabia
        • 12.6.1.1.1 Rising healthcare expenditure to boost market growth
      • 12.6.1.2 UAE
        • 12.6.1.2.1 Increasing collaborations among biopharma companies to aid market growth
      • 12.6.1.3 Rest of GCC countries
    • 12.6.2 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 INCREASING DEMAND FOR DRUGS AND GROWING PATIENT POOL TO PROPEL MARKET GROWTH

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE BIOREACTORS MARKET
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Product footprint
      • 13.5.5.4 Application footprint
      • 13.5.5.5 End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.7.1 FINANCIAL METRICS
    • 13.7.2 COMPANY VALUATION
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 SARTORIUS AG
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches
        • 14.1.1.3.2 Deals
        • 14.1.1.3.3 Expansions
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 DANAHER CORPORATION
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 THERMO FISHER SCIENTIFIC INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Deals
        • 14.1.3.3.2 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 MERCK KGAA
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches
        • 14.1.4.3.2 Deals
        • 14.1.4.3.3 Expansions
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Right to win
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses and competitive threats
    • 14.1.5 AVANTOR, INC.
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
        • 14.1.5.3.2 Expansions
    • 14.1.6 REPLIGEN CORPORATION
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
        • 14.1.6.3.2 Expansions
    • 14.1.7 GETINGE AB
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product launches
        • 14.1.7.3.2 Deals
        • 14.1.7.3.3 Expansions
    • 14.1.8 EPPENDORF SE
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches
    • 14.1.9 PARKER HANNIFIN CORPORATION
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
    • 14.1.10 ENTEGRIS
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Expansions
    • 14.1.11 SAINT-GOBAIN
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
        • 14.1.11.3.2 Expansions
    • 14.1.12 CORNING INCORPORATED
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
    • 14.1.13 LONZA
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products offered
    • 14.1.14 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product launches
        • 14.1.14.3.2 Deals
        • 14.1.14.3.3 Expansions
    • 14.1.15 FUJIMORI KOGYO CO., LTD.
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Expansions
  • 14.2 OTHER PLAYERS
    • 14.2.1 KUHNER AG
    • 14.2.2 OMNIBRX BIOTECHNOLOGIES
    • 14.2.3 NEW HORIZON BIOTECHNOLOGY, INC.
    • 14.2.4 PBS BIOTECH, INC.
    • 14.2.5 BBI-BIOTECH GMBH
    • 14.2.6 ABEC, INC.
    • 14.2.7 ESCO LIFESCIENCES GROUP LTD.
    • 14.2.8 DISTEK, INC.
    • 14.2.9 SATAKE MULTIMIX CORPORATION
    • 14.2.10 CELL CULTURE COMPANY, LLC
    • 14.2.11 MICRO DIGITAL CO., LTD.
    • 14.2.12 CELLTAINER BIOTECH B.V.
    • 14.2.13 MEISSNER FILTRATION PRODUCTS, INC.
    • 14.2.14 SOLIDA BIOTECH GMBH
    • 14.2.15 G&G TECHNOLOGIES, INC.
    • 14.2.16 PHARMNXT BIOTECH
    • 14.2.17 TOFFLON LIFE SCIENCE CO., LTD.
    • 14.2.18 SHANGHAI LEPURE BIOTECH CO., LTD.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 SINGLE-USE BIOREACTORS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 SINGLE-USE BIOREACTORS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS
  • TABLE 5 COMPARISON OF SINGLE-USE AND MULTIUSE BIOREACTORS
  • TABLE 6 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS (COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE)
  • TABLE 7 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS
  • TABLE 8 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS
  • TABLE 9 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYERS, 2023
  • TABLE 10 INDICATIVE PRICING ANALYSIS OF SINGLE-USE BIOREACTORS, BY REGION, 2023
  • TABLE 11 SINGLE-USE BIOREACTORS MARKET: RAW MATERIAL SUPPLIERS
  • TABLE 12 SINGLE-USE BIOREACTORS MARKET: MANUFACTURERS
  • TABLE 13 SINGLE-USE BIOREACTORS MARKET: END USERS
  • TABLE 14 SINGLE-USE BIOREACTORS MARKET: REGULATORY BODIES
  • TABLE 15 SINGLE-USE BIOREACTORS: COMPLEMENTARY TECHNOLOGIES
  • TABLE 16 SINGLE-USE BIOREACTORS: ADJACENT TECHNOLOGIES
  • TABLE 17 KEY PATENTS IN SINGLE-USE BIOREACTORS MARKET
  • TABLE 18 SINGLE-USE BIOREACTORS MARKET: CONFERENCES AND EVENTS, 2024-2025
  • TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 SINGLE-USE BIOREACTORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 25 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS, BY END USER
  • TABLE 26 IMPORT VALUE FOR HS CODE 841989, 2019-2023 (USD THOUSAND)
  • TABLE 27 EXPORT VALUE FOR HS CODE 841989, 2019-2023 (USD THOUSAND)
  • TABLE 28 IMPORT VOLUME FOR HS CODE 841989, 2019-2023 (TONS)
  • TABLE 29 EXPORT VOLUME FOR HS CODE 841989, 2019-2023 (TONS)
  • TABLE 30 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 31 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS OFFERED BY MARKET PLAYERS
  • TABLE 32 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2022-2029 (USD MILLION)
  • TABLE 33 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 NORTH AMERICA: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 EUROPE: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 LATIN AMERICA: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 MIDDLE EAST: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 GCC COUNTRIES: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 EUROPE: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 LATIN AMERICA: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 MIDDLE EAST: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 GCC COUNTRIES: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 MIDDLE EAST: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 GCC COUNTRIES: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 GCC COUNTRIES: 501-1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 EUROPE: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 MIDDLE EAST: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 GCC COUNTRIES: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 LATIN AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 MIDDLE EAST: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 GCC COUNTRIES: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 2D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 EUROPE: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 LATIN AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 MIDDLE EAST: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 3D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 LATIN AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 MIDDLE EAST: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 GCC COUNTRIES: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 OTHER SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 MIDDLE EAST: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 GCC COUNTRIES: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 EXAMPLES OF SINGLE-USE STIRRED-TANK BIOREACTOR SYSTEMS FOR STEM CELL CULTURE
  • TABLE 120 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 MIDDLE EAST: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 MIDDLE EAST: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 GCC COUNTRIES: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 MIDDLE EAST: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 GCC COUNTRIES: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 142 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 MIDDLE EAST: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 164 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 191 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 214 US: NUMBER OF PRODUCTS GOING OFF-PATENT, 2023-2028
  • TABLE 215 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 216 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 223 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 227 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 230 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 232 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 233 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 234 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 237 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 238 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 241 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 245 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 248 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 252 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 255 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 256 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 259 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 267 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 268 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 269 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 US: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 US: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 US: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 275 US: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 276 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 277 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 CANADA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 CANADA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 CANADA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 283 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 284 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 285 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 286 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 292 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 293 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 294 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 GERMANY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 297 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 300 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 301 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 302 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 303 UK: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 UK: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 UK: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 308 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 309 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 310 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 311 FRANCE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 316 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 317 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 318 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 ITALY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 321 ITALY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 ITALY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 323 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 324 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 325 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 326 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 SPAIN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 332 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 333 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 334 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 REST OF EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 340 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 350 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 351 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 CHINA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 CHINA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 CHINA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 357 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 358 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 359 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 SOUTH KOREA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 365 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 366 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 367 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 JAPAN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 373 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 374 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 375 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 INDIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 INDIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 INDIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 380 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 381 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 382 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 383 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 AUSTRALIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 389 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 390 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 391 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 396 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 397 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 403 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 406 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 407 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 408 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 BRAZIL: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 412 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 414 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 415 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 416 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 MEXICO: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 422 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 423 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 424 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 430 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 431 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 432 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 433 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 434 MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 439 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 440 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 441 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 442 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 445 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 448 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 449 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 450 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 451 SAUDI ARABIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 452 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 454 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 456 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 457 UAE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 458 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 UAE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 UAE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 461 UAE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 462 UAE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 UAE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 464 UAE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 465 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 466 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 467 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 468 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 469 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 472 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 473 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 474 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 475 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 477 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 478 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 480 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 481 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 482 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 AFRICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 484 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
  • TABLE 486 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 488 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 489 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES, 2021-2024
  • TABLE 490 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION
  • TABLE 491 SINGLE-USE BIOREACTORS MARKET: REGION FOOTPRINT
  • TABLE 492 SINGLE-USE BIOREACTORS MARKET: PRODUCT FOOTPRINT
  • TABLE 493 SINGLE-USE BIOREACTORS MARKET: APPLICATION FOOTPRINT
  • TABLE 494 SINGLE-USE BIOREACTORS MARKET: END-USER FOOTPRINT
  • TABLE 495 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 496 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 497 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 498 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 499 SINGLE-USE BIOREACTORS MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 500 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 501 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 502 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 503 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 504 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 505 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 506 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 507 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 508 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 509 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 510 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 511 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 512 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 513 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 514 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 515 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 516 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 517 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 518 AVANTOR, INC.: COMPANY OVERVIEW
  • TABLE 519 AVANTOR, INC.: PRODUCTS OFFERED
  • TABLE 520 AVANTOR, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 521 AVANTOR, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 522 REPLIGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 523 REPLIGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 524 REPLIGEN CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 525 REPLIGEN CORPORATION: EXPANSION, JANUARY 2021–JUNE 2024
  • TABLE 526 GETINGE AB: COMPANY OVERVIEW
  • TABLE 527 GETINGE AB: PRODUCTS OFFERED
  • TABLE 528 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 529 GETINGE AB: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 530 GETINGE AB: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 531 EPPENDORF SE: COMPANY OVERVIEW
  • TABLE 532 EPPENDORF SE: PRODUCTS OFFERED
  • TABLE 533 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 534 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW
  • TABLE 535 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED
  • TABLE 536 ENTEGRIS: COMPANY OVERVIEW
  • TABLE 537 ENTEGRIS: PRODUCTS OFFERED
  • TABLE 538 ENTEGRIS: EXPANSION, JANUARY 2021–JUNE 2024
  • TABLE 539 SAINT-GOBAIN: COMPANY OVERVIEW
  • TABLE 540 SAINT-GOBAIN: PRODUCTS OFFERED
  • TABLE 541 SAINT-GOBAIN: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 542 SAINT-GOBAIN: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 543 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 544 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 545 LONZA: COMPANY OVERVIEW
  • TABLE 546 LONZA: PRODUCTS OFFERED
  • TABLE 547 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY OVERVIEW
  • TABLE 548 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCTS OFFERED
  • TABLE 549 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 550 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 551 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 552 FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW
  • TABLE 553 FUJIMORI KOGYO CO., LTD.: PRODUCTS OFFERED
  • TABLE 554 FUJIMORI KOGYO CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 555 KUHNER AG: COMPANY OVERVIEW
  • TABLE 556 OMNIBRX BIOTECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 557 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 558 PBS BIOTECH, INC.: COMPANY OVERVIEW
  • TABLE 559 BBI-BIOTECH GMBH: COMPANY OVERVIEW
  • TABLE 560 ABEC, INC.: COMPANY OVERVIEW
  • TABLE 561 ESCO LIFESCIENCES GROUP LTD.: COMPANY OVERVIEW
  • TABLE 562 DISTEK, INC.: COMPANY OVERVIEW
  • TABLE 563 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW
  • TABLE 564 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW
  • TABLE 565 MICRO DIGITAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 566 CELLTAINER BIOTECH B.V.: COMPANY OVERVIEW
  • TABLE 567 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 568 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
  • TABLE 569 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 570 PHARMNXT BIOTECH: COMPANY OVERVIEW
  • TABLE 571 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW
  • TABLE 572 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOREACTORS MARKET
  • FIGURE 3 SINGLE-USE BIOREACTORS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINGLE-USE BIOREACTORS MARKET
  • FIGURE 17 RISING DEMAND FOR BIOLOGICS AND ADVANTAGES OF SUBS OVER CONVENTIONAL BIOREACTORS ARE EXPECTED TO PROPEL MARKET
  • FIGURE 18 BIOPRODUCTION APPLICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 20 CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY
  • FIGURE 23 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY
  • FIGURE 24 BIOSIMILAR APPROVALS & LAUNCHES, 2015-2023
  • FIGURE 25 REVENUE SHIFTS IN SINGLE-USE BIOREACTORS MARKET
  • FIGURE 26 SINGLE-USE BIOREACTORS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 SINGLE-USE BIOREACTORS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 SINGLE-USE BIOREACTORS MARKET: ECOSYSTEM
  • FIGURE 29 NUMBER OF PATENTS GRANTED, 2014-2024
  • FIGURE 30 SINGLE-USE BIOREACTORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTORS PRODUCTS
  • FIGURE 32 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS AMONG END USERS
  • FIGURE 33 PHARMACEUTICAL R&D SPENDING, 2014-2028 (USD BILLION)
  • FIGURE 34 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 35 US: FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2014-2024
  • FIGURE 36 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2019-2023
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 39 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 SINGLE-USE BIOREACTORS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 SINGLE-USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 49 AVANTOR, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 GETINGE AB: COMPANY SNAPSHOT (2023)
  • FIGURE 52 EPPENDORF SE: COMPANY SNAPSHOT (2023)
  • FIGURE 53 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 ENTEGRIS: COMPANY SNAPSHOT (2023)
  • FIGURE 55 SAINT-GOBAIN: COMPANY SNAPSHOT (2023)
  • FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 57 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 58 FUJIMORI KOGYO CO., LTD.: COMPANY SNAPSHOT (2023)